Abstract
RCSN-3 cells are a cloned cell line derived from the substantia nigra of an adult rat. The cell line grows in monolayer and does not require differentiation to express catecholaminergic traits, such as (i) tyrosine hydroxylase; (ii) dopamine release; (iii) dopamine transport; (iv) norepinephrine transport; (v) monoamine oxidase (MAO)-A expression, but not MAO-B; (vi) formation of neuromelanin; (vii) vesicular monoamine transporter-2 (VMAT-2) expression. In addition, this cell line expresses serotonin transporters, divalent metal transporter, DMT1, dopamine receptor 1 mRNA under proliferating conditions, and dopamine receptor 5 mRNA after incubation with dopamine or dicoumarol. Expression of dopamine receptors D2, D3 and D4 mRNA were not detected in proliferating cells or when the cells were treated with dopamine, CuSO4, dicoumarol or dopamine-copper complex. Angiotensin II receptor mRNA was also found to be expressed, but it underwent down regulation in the presence of aminochrome. Total quinone reductase activity corresponded 94% to DT-diaphorase. The cells also express antioxidant enzymes such as superoxide dismutase, catalase and glutathione peroxidase. This cell line is a suitablein vitro model for studies of dopamine metabolism, since under proliferating conditions the cells express all the pertinent markers.
Similar content being viewed by others
References
Aguilar Hernandez R, MJ Sanchez De Las Matas, C Arriagada, C Barcia, P Caviedes, MT Herrero and J Segura-Aguilar (2003) MPP+-induced degeneration is potentiated by dicoumarol in cultures of the RCSN-3 dopaminergic cell line. Implications of neuromelanin in oxidative metabolism of dopamine neurotoxicity.Neurotox. Res. 5, 407–410.
Arriagada C, J Salazar, T Shimahara, R Caviedes and P Caviedes (2002) An immortalized neuronal cell line derived from the substantia nigra of an adult rat: application to cell transplant therapy, In:Parkinson’s Disease (Ronken E and G van Scharrenburg, Eds) (IOS Press:Amsterdam, The Netherlands) ISBN 1 58603 207 0, pp 120–132.
Arriagada A, I Paris, MJ Sanchez de las Matas, P Martinez-Alvarado, S Cardenas, P Castañeda, R Graumann, C Perez-Pastene, C Olea-Azar, E Couve, MT Herrero, P Caviedes and J Segura-Aguilar (2004) On the neurotoxicity of leukoaminochromeo-semiquinone radical derived of dopamine oxidation: mitochondria damage, necrosis and hydroxyl radical formation.Neurobiol. Dis. 16, 468–477.
Berg D, H Hochstrasser, KJ Schweitzer and O Riess (2006) Disturbance of iron metabolism in Parkinson’s disease - ultrasonography as a biomarker.Neurotox. Res. 9, 1–13.
Caviedes P, E Olivares, K Salas, R Caviedes and E Jaimovich (1993) Calcium fluxes, ion currents and dihydropyridine receptors in a newly established cell line from rat heart muscle.J. Mol. Cell Cardiol. 25, 829–845.
Caviedes R, P Caviedes, JL y Liberona and E Jaimovich (1994) Ion currents in a skeletal muscle cell line from a Duchenne muscular dystrophy patient.Muscle & Nerve 17, 1021–1028.
Caviedes P, R Caviedes, TB Freeman, PR Sanberg and DF Cameron (2002)Proliferated Cell Lines and Uses Thereof. International Publication number WO 03/065999 A2. Filed Feb. 8th, 2002, publication date: August 14th, 2003. World Intellectual Property Organization, International Bureau.
Chiasson K, B Daoust, D Levesque and MG Martinoli (2006) Dopamine D2 agonists, bromocriptine and quinpirole, increase MPP+-induced toxicity in PC12 cells.Neurotox. Res. 10, 31–42.
Copeland RL Jr, YA Leggett, YM Kanaan, RE Taylor and Y Tizabi (2005) Neuroprotective effects of nicotine against salsolinol-induced cytotoxicity: implications for Parkinson’s disease.Neurotox. Res. 8, 289–293.
Dagnino-Subiabre A, K Marcelain, C Arriagada, I Paris, P Caviedes, R Caviedes and J Segura-Aguilar (2000) Angiotensin receptor II is present in dopaminergic cell line of rat substantia nigra and it is down regulated by aminochrome.Mol. Cell. Biochem. 212, 131–134.
Duka T and A Sidhu (2006) The neurotoxin, MPP+, induces hyperphosphorylation of tau, in the presence of α-synuclein, in SH-SY5Y neuroblastoma cells.Neurotox. Res. 10, 1–10.
Fuentes-Bravo P, P Martinez-Alvarado, S Cardenas, J Lozano, I Paris, C Perez-Pastene, R Graumann, P Caviedes and J Segura-Aguilar (2005) Inhibition of VMAT-2 and DT-diaphorase induce neurotoxicity via apoptosis.Neurotox. Res. 8, 339. Abstr.
Fuentes P, I Paris I, M Nassif, P Caviedes and J Segura-Aguilar (2007) Inhibition of VMAT-2 and DT-diaphorase induce cell death in aSubstantia nigra-derived cell line - an experimental cell model for dopamine toxicity studies.Chem. Res. Toxicol. 20, 776–783.
Greene LA. and AS Tischler (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.Proc. Natl. Acad. Sci. USA 73, 2424–2428.
Greene LA and AS Tischler (1982) PC12 pheochromocytoma cells in neurobiological research.Adv. Cell. Neurobiol. 3, 373–414.
Hasegawa T, M Matsuzaki, A Takeda, A Kikuchi, K Furukawa, S Shibahara and Y Itoyama (2003) Increased dopamine and its metabolites in SH-SY5Y neuroblastoma cells that express tyrosinase.J. Neurochem. 87, 470–475.
Hashimoto W, S Kitayama, K Kumagai, N Morioka, K Morita and T Dohi (2005) Transport of dopamine and levodopa and their interaction in COS-7 cells heterologously expressing monoamine neurotransmitter transporters and in monoaminergic cell lines PC12 and SK-N-SH.Life Sci. 76, 1603–1612.
Jackson-Lewis V and RJ Smeyne (2005) MPTP and SNpc DA neuronal vulnerability: role of dopamine, superoxide and nitric oxide in neurotoxicity.Neurotox. Res. 7, 193–202.
Jiang H, Q Jiang and J Feng (2004) Parkin increases dopamine uptake by enhancing the cell surface expression of dopamine transporter.J. Biol. Chem. 279, 54380–54386.
King SC, AA Tiller, AS Chang and DM Lam (1992) Differential regulation of the imipramine-sensitive serotonin transporter by cAMP in human JAr choriocarcinoma cells, rat PC12 pheochromocytoma cells, and C33-14-B1 transgenic mouse fibroblast cells.Biochem. Biophys. Res. Commun. 183, 487–491.
Langer AK, HF Poon, G Münch, BC Lynn, T Arendt, and DA Butterfield (2006) Identification of AGE-modified proteins in SH-SY5Y and OLN-93 cells.Neurotox. Res. 9, 255–268
Lozano-Gonzalez J, SP Cárdenas, P Martinez-Alvarado, P Fuentes-Bravo, C Perez-Pastene, R Graumman, I Paris and J Segura-Aguilar (2005) DT-Diaphorase and their relationship with dopamine oxidative metabolism and neurodegeneration in RCSN-33 cells derived ofSubstantia nigra of rat.Neurotox. Res. 8, 324. Abstr.
Lu J, CS Park, SK Lee, DW Shin and JH Kang (2006) Leptin inhibits 1-methyl-4-phenylpyridinium-induced cell death in SH-SY5Y cells.Neurosci. Lett. 407, 240–243.
Martinez-Alvarado P, A Dagnino-Subiabre, I Paris, D Metodiewa, C Welch, C Olea-Azar, P Caviedes, R Caviedes and J Segura-Aguilar (2001) Possible role of salsolinol quinone methide on RCSN-3 cells survival decrease.Biochem. Biophys. Res. Commun. 283, 1069–1076.
Martínez-Alvarado P, P Fuentes-Bravo, S Cardenas, C Arriagada, I Paris, C Perez-Pastene, J Lozano, R Graumann, P Caviedes and J Segura-Aguilar (2005) Cell diferentiation in a catecholaminergic cell line (RCSN-33).Neurotox. Res. 8, 3. Abstr.
Massicotte C, K Knight, CJ Van der Schyf, BS Jortner and M Ehrich (2005) Effects of organophosphorus compounds on ATP production and mitochondrial integrity in cultured cells.Neurotox. Res. 7, 203–217.
Mehler-Wex C, P Riederer and M Gerlach (2006) Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson’s disease, schizophrenia and attention deficit hyperactivity disorder.Neurotox. Res. 10, 167–79.
Paris I, A Dagnino-Subiabre, K Marcelain, LB Bennett, P Caviedes, R Caviedes, C Olea-Azar and J Segura-Aguilar (2001) Copper neurotoxicity is dependent on dopaminemediated copper uptake and one-electron reduction of aminochrome in a rat substantia nigra neuronal cell line.J. Neurochem. 77, 519–529.
Paris I, P Martinez-Alvarado, C Perez-Pastene, MN Vieira, C Olea-Azar, R Raisman-Vozari, S Cardenas, R Graumann, P Caviedes and J Segura-Aguilar (2005a) Monoamine transporter inhibitors and norepinephrine reduce dopaminedependent iron toxicity in cells derived from the substantia nigra.J. Neurochem. 92, 1021–1032.
Paris I, P Martinez-Alvarado, S Cardenas, C Perez-Pastene, R Graumann, P Fuentes, C Olea-Azar, P Caviedes and J Segura-Aguilar (2005b) Dopamine-dependent iron toxicity in cells derived from rat hypothalamus.Chem. Res. Toxicol. 18, 415–419.
Paris I, P Martinez-Alvarado, C Perez-Pastene, MN Vieira, C Olea-Azar, R Raisman-Vozari, S Cardenas, R Graumann, P Caviedes and J Segura-Aguilar (2005c) Monoamine transporter inhibitors and norepinephrine reduce dopaminedependent iron toxicity in cells derived from the substantia nigra.J. Neurochem. 92, 1021–1032.
Paris I, C Perez-Pastene, P Martinez-Alvarado, R Graumann, P Fuentes, J Lozano, S Cárdenas, C Olea-Azar, P Caviedes and J Segura-Aguilar (2005d) Dopamine-dependent iron toxicity in cells derived from rat hypothalamus - the role of norepinephrine transport.Neurotox. Res. 8, 338. Abstr.
Paris I, C Perez-Pastene, P Martinez-Alvarado, R Graumann, P Fuentes, J Lozano, S Cárdenas, C Olea-Azar, P Caviedes and J Segura-Aguilar (2005e) On the mechanism of dopamine- dependent copper toxicity.Neurotox. Res. 8, 330.Abstr.
Paris I, C Perez-Pastene, P Martinez-Alvarado, R Graumann, P Fuentes, J Lozano, S Cárdenas, C Olea-Azar, P Caviedes and J Segura-Aguilar (2005f) DT-Diaphorase, monoaminergic transporter inhibitors and norepinephine prevent dopamine- dependent iron toxicity in cells derived from the Substantia nigra.Neurotox. Res. 8, 335. Abstr.
Paris I, C Arriagada, C Perez-Pastene, P Martinez-Alvarado, R Graumann, P Fuentes, J Lozano, S Cardenas, C Olea-Azar, P Caviedes and J Segura-Aguilar (2007a) On the neurotoxicity mechanism of leukoaminochrome o-semiquinone radical derived from dopamine oxidation: mitochondria damage, necrosis, and hydroxyl radical formation.Neurotox. Res. 8, 328 Abstr.
Paris I, S Cardenas, J Lozano, C Perez-Pastene, R Graumann, A Riveros, P Caviedes and J Segura-Aguilar (2007b) Aminochrome as a preclinical experimental model to study degeneration of dopaminergic neurons in Parkinson’s disease.Neurotox. Res. 12(2), 125–134. Review.
Segura-Aguilar J and RM Kostrzewa (2006) Neurotoxins and neurotoxicity mechanisms. An overview.Neurotox. Res. 10, 263–287.
Seitz G, HB Stegmann, HH Jäger, HM Schlude, H Wolburg, VA Roginsky, D Niethammer and G Bruchelt (2000) Neuroblastoma cells expressing the noradrenaline transporter are destroyed more selectively by 6-fluorodopamine than by 6-hydroxydopamine.J. Neurochem. 75, 511–520.
Sulzer D, J Bogulavsky, KE Larsen, G Behr, E. Karatekin, MH Kleinman, N Turro, D Krantz, RH Edwards, LA Greene and L Zecca (2000) Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.Proc. Natl. Acad. Sci. USA 97, 11869–11874.
Xu Z, D Cawthon, KA McCastlain, HM Duhart, GD Newport, H Fang, TA Patterson, W Slikker and SF Ali (2005) Selective alterations of transcription factors in MPP+- induced neurotoxicity in PC12 cells.Neurotoxicology 26, 729–737.
Author information
Authors and Affiliations
Corresponding author
Additional information
†Please address correspondence regarding use of the RCSN-3 line to Pablo Caviedes (pcaviede@med.uchile.cl)
Rights and permissions
About this article
Cite this article
Paris, I., Lozano, J., Cardenas, S. et al. The catecholaminergic RCSN-3 cell line: A model to study dopamine metabolism. neurotox res 13, 221–230 (2008). https://doi.org/10.1007/BF03033505
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03033505